Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1056, doi. 10.1111/liv.13382
- By:
- Publication type:
- Article
Works matching IS 14783223 AND DT 2017 AND VI 37 AND IP 7
Results: 24
1
2
Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 974, doi. 10.1111/liv.13336
- By:
- Publication type:
- Article
3
Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 950, doi. 10.1111/liv.13337
- By:
- Publication type:
- Article
4
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 982, doi. 10.1111/liv.13339
- By:
- Publication type:
- Article
5
Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1065, doi. 10.1111/liv.13284
- By:
- Publication type:
- Article
6
Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1082, doi. 10.1111/liv.13161
- By:
- Publication type:
- Article
7
HBV reactivation after HCV eradication: Deja Vu.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1088, doi. 10.1111/liv.13358
- By:
- Publication type:
- Article
8
mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1047, doi. 10.1111/liv.13359
- By:
- Publication type:
- Article
9
Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1042, doi. 10.1111/liv.13423
- By:
- Publication type:
- Article
10
Therapeutic targeting of the mitochondrial reactive oxygen species engine prevents portal hypertension and hepatic fibrogenesis.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
11
Malignant potential of hepatocellular adenoma.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
12
HCV/HBV coinfection: The dark side of DAAs treatment?
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1086, doi. 10.1111/liv.13342
- By:
- Publication type:
- Article
13
Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1013, doi. 10.1111/liv.13345
- By:
- Publication type:
- Article
14
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 995, doi. 10.1111/liv.13346
- By:
- Publication type:
- Article
15
Issue Information.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 931, doi. 10.1111/liv.13229
- Publication type:
- Article
16
Hepatic resection is superior to transarterial chemoembolization for treating intermediate-stage hepatocellular carcinoma.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1083, doi. 10.1111/liv.13290
- By:
- Publication type:
- Article
17
Lipopolysaccharide binding protein predicts decompensated cirrhosis mortality? It is too early.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1084, doi. 10.1111/liv.13295
- By:
- Publication type:
- Article
18
Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1074, doi. 10.1111/liv.13362
- By:
- Publication type:
- Article
19
Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1023, doi. 10.1111/liv.13368
- By:
- Publication type:
- Article
20
Low transferrin and high ferritin concentrations are associated with worse outcome in acute liver failure.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1032, doi. 10.1111/liv.13369
- By:
- Publication type:
- Article
21
Interleukin-1 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 968, doi. 10.1111/liv.13430
- By:
- Publication type:
- Article
22
The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 936, doi. 10.1111/liv.13435
- By:
- Publication type:
- Article
23
Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1002, doi. 10.1111/liv.13436
- By:
- Publication type:
- Article
24
Response to Lipopolysaccharide binding protein predicts decompensated cirrhosis mortality? It is too early.
- Published in:
- Liver International, 2017, v. 37, n. 7, p. 1085, doi. 10.1111/liv.13313
- By:
- Publication type:
- Article